170 related articles for article (PubMed ID: 9054731)
1. Confusion in reperfusion. Problems in the clinical development of antithrombotic drugs.
Catella-Lawson F; FitzGerald GA
Circulation; 1997 Feb; 95(4):793-5. PubMed ID: 9054731
[No Abstract] [Full Text] [Related]
2. Flow cytometric monitoring of glycoprotein IIb/IIIa blockade and platelet function in patients with acute myocardial infarction receiving reteplase, abciximab, and ticlopidine: continuous platelet inhibition by the combination of abciximab and ticlopidine.
Peter K; Kohler B; Straub A; Ruef J; Moser M; Nordt T; Olschewski M; Ohman ME; Kübler W; Bode C
Circulation; 2000 Sep; 102(13):1490-6. PubMed ID: 11004138
[TBL] [Abstract][Full Text] [Related]
3. Facilitated percutaneous intervention following combination therapy with reteplase and abciximab for acute myocardial infarction.
Weinstock BS
J Invasive Cardiol; 2002 Feb; 14(2):100-4; quiz 104-5. PubMed ID: 11818648
[No Abstract] [Full Text] [Related]
4. [Antithrombotic therapy during percutaneous coronary interventions].
Verheugt FW; Dieker H; Aengevaeren WR
Ned Tijdschr Geneeskd; 2005 Apr; 149(17):912-6. PubMed ID: 15884403
[TBL] [Abstract][Full Text] [Related]
5. GUSTO V: combination drug treatment of acute myocardial infarction. Global Use of Strategies to Open Occluded Coronary Arteries.
Askari AT; Lincoff AM
Cleve Clin J Med; 2002 Jul; 69(7):554-60. PubMed ID: 12109639
[TBL] [Abstract][Full Text] [Related]
6. Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines.
Mehta SR;
J Invasive Cardiol; 2002 Dec; 14 Suppl E():27E-34E; quiz 35E. PubMed ID: 12668860
[TBL] [Abstract][Full Text] [Related]
7. Micro stent implantation in patients with acute myocardial infarction without anticoagulation: clinical experience with two different antithrombotic protocols.
Oemrawsingh PV; Schalij MJ; Udayachalerm W; van der Wall EE; Bruschke AV
Cathet Cardiovasc Diagn; 1998 Jun; 44(2):131-7. PubMed ID: 9637432
[TBL] [Abstract][Full Text] [Related]
8. Blocking platelets more: are we skating on thin ice?
Choussat R; Montalescot G
Heart; 1998 Jan; 79(1):5-6. PubMed ID: 9505907
[No Abstract] [Full Text] [Related]
9. Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial.
Antman EM; Louwerenburg HW; Baars HF; Wesdorp JC; Hamer B; Bassand JP; Bigonzi F; Pisapia G; Gibson CM; Heidbuchel H; Braunwald E; Van de Werf F
Circulation; 2002 Apr; 105(14):1642-9. PubMed ID: 11940541
[TBL] [Abstract][Full Text] [Related]
10. [Antithrombotic treatment of acute coronary syndromes without ST-segment elevation].
Radke PW; Schunkert H
Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S204-7. PubMed ID: 17109249
[No Abstract] [Full Text] [Related]
11. Evolution of improved antithrombotic and antiplatelet agents: genesis of the Comparison of Abciximab Complications with Hirulog [and back-Up Abciximab] Events Trial (CACHET).
Topol EJ
Am J Cardiol; 1998 Oct; 82(8B):63P-68P. PubMed ID: 9809894
[TBL] [Abstract][Full Text] [Related]
12. GUSTO V: should it affect clinical practice? Global Use of Strategies to Open Occluded Coronary Arteries.
Orford JL; Berger PB
Cleve Clin J Med; 2002 Jul; 69(7):520-2. PubMed ID: 12109634
[No Abstract] [Full Text] [Related]
13. [Optimal antiplatelet and antithrombotic therapy in patients with ST elevation myocardial infarction].
Koziński M; Grześk G; Kubica J
Kardiol Pol; 2012; 70(2):206-12. PubMed ID: 22427098
[No Abstract] [Full Text] [Related]
14. Outcome of acute myocardial infarction in patients with prior coronary artery bypass grafting treated with combination reduced fibrinolytic therapy and abciximab.
Mukherjee D; Gurm H; Tang WH; Roffi M; Wolski K; Moliterno DJ; Guetta V; Ardissinio D; Bode C; Steg G; Lincoff AM; Topol EJ
Am J Cardiol; 2002 Dec; 90(11):1198-203. PubMed ID: 12450598
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial comparing clopidogrel versus ticlopidine therapy in patients undergoing infarct artery stenting for acute myocardial infarction with abciximab as adjunctive therapy.
Parodi G; Sciagrà R; Migliorini A; Memisha G; Moschi G; Valenti R; Pupi A; Antoniucci D
Am Heart J; 2005 Aug; 150(2):220. PubMed ID: 16086921
[TBL] [Abstract][Full Text] [Related]
16. Restoration of coronary flow in myocardial infarction by intravenous chimeric 7E3 antibody without exogenous plasminogen activators. Observations in animals and humans.
Gold HK; Garabedian HD; Dinsmore RE; Guerrero LJ; Cigarroa JE; Palacios IF; Leinbach RC
Circulation; 1997 Apr; 95(7):1755-9. PubMed ID: 9107158
[TBL] [Abstract][Full Text] [Related]
17. Combined fibrinolysis using reduced-dose alteplase plus abciximab with immediate rescue angioplasty versus primary angioplasty with adjunct use of abciximab for the treatment of acute myocardial infarction: Asia-Pacific Acute Myocardial Infarction Trial (APAMIT) pilot study.
Wong A; Mak KH; Chan C; Koh TH; Lau KW; Lim TT; Lim ST; Wong P; Sim LL; Lim YT; Tan HC; Lim YL
Catheter Cardiovasc Interv; 2004 Aug; 62(4):445-52. PubMed ID: 15274152
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of a high on-clopidogrel treatment platelet reactivity in bivalirudin versus abciximab treated non-ST-segment elevation myocardial infarction patients. ISAR-REACT 4 (Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment-4) platelet substudy.
Sibbing D; Bernlochner I; Schulz S; Massberg S; Schömig A; Mehilli J; Kastrati A
J Am Coll Cardiol; 2012 Jul; 60(5):369-77. PubMed ID: 22682553
[TBL] [Abstract][Full Text] [Related]
19. Thrombin generation and fibrinolytic activities among patients receiving reduced-dose alteplase plus abciximab or undergoing direct angioplasty plus abciximab for acute myocardial infarction.
Mak KH; Lee LH; Wong A; Chan C; Koh TH; Lau KW; Lim YL
Am J Cardiol; 2002 Apr; 89(8):930-6. PubMed ID: 11950430
[TBL] [Abstract][Full Text] [Related]
20. Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: lessons from the GUSTO V trial.
Gurm HS; Lincoff AM; Lee D; Tang WH; Jia G; Booth JE; Califf RM; Ohman EM; Van de Werf F; Armstrong PW; Guetta V; Wilcox R; Topol EJ;
J Am Coll Cardiol; 2004 Feb; 43(4):542-8. PubMed ID: 14975461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
